• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Mankind Pharma targets Rs 1,000-cr turnover

      Posted AtSify.com

      Mankind Pharma has set itself an ambitious target of achieving a turnover of Rs 1,000 crore in the next five years.To achieve this, the company plans to invest Rs 70 crore in the next two years in scaling up its manufacturing capability and investing in research and development (R&D).

      According to R.C. Juneja, Managing Director, Mankind Pharma, a new manufacturing plant complying with the US Food and Drug Administration standards is being set up in Poanta Sahib, Himachal Pradesh."Mankind will set up a latest R&D facility in the national capital region (NCR). This facility will have capabilities in the areas of formulations development, new drug delivery systems, bio-equivalence studies, contract research and new drug discovery," he said.

      Mankind Pharma is also planning to export its products to other semi-regulated markets of South East Asia, South African and some CIS countries. "We hope that exports will contribute 10 per cent to the annual turnover," said Rajiv Juneja, Director, Marketing. In India too, it will add a new division to its existing ones by the end of 2007 which will comprise oncology and other critical care segment drugs.

      The domestic formulations business is expected to grow at 40 per cent. Domestic sales will continue to be the cornerstone of the growth strategy. "Currently, we have a 1900 strong field force. Over the next two years, this number is likely to grow to 3,000 people," he added.

      December 16, 2005


      Share this Article!

    Back to top^